Synergistic effect of cefixime and cloxacillin combination against common bacterial pathogens causing community acquired pneumonia

Indian Journal of Pharmacology

Volumn 39, Issue 5, 2007, Pages 251-252

  Agarwal, Astha ^a   Jain, N ^a   Jain, A ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFIXIME; CHLORAMPHENICOL; CLOXACILLIN;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; COMMUNITY ACQUIRED PNEUMONIA; DRUG POTENTIATION; HUMAN; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 36849059854     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.37278     Document Type: Article

References (5)

1. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32:S81-93.
2. th Informational Supplement testing M100-S15, CLSI: 2005.
3. Feldman WE. Effect of ampicillin and chloramphenicol against Haemophilus influenzae. Pediatrics 1978;61:406-9.
4. Salvarezza CR, Mingrone H, Fachinelli H, Kijanczuk S. Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia. J Antimicrob Chemother 1998;41:75-80.
5. Hewitt WL. The generation cephalosporins. In: Remington JS, Swartz MN, editors. Current clinical topics in infectious disease (4). McGraw-Hill Book Co: New York; 1983. p. 403-23.